Skip to main content
. 2019 Sep 12;17(9):e05780. doi: 10.2903/j.efsa.2019.5780

Figure 6.

Figure 6

Overview of the endpoints considered in main and supportive lines of evidence and those that could not be used for this assessment

  • aBMC: areal bone mineral content; BMD: bone mineral density; BMI: body mass index; BMIZ: body mass index‐for‐age z‐score; CD: coeliac disease; CF: complementary food; CVD: cardiovascular disease; DBP: diastolic blood pressure; EBF: exclusively breastfed; HC: head circumference; HCZ: head circumference‐for‐age z‐score; JIA: juvenile idiopathic arthritis; L(H)AZ: length(height)‐for‐age z‐score; m: months; NAFLD: non‐alcoholic fatty liver disease; PE: point estimate; RCT: randomised controlled trial; SBP: systolic blood pressure; SFT: skinfold thickness; T1DM: type 1 diabetes mellitus; WAZ: weight‐for‐age z‐score; WLZ: weight length z‐score WL(H)Z: weight‐length(height)‐for‐age z‐score.